Rifampicin 300mg and Isoniazide 150mg Tablets Manufacturer in India

Leading Manufacturer of Rifampicin 300mg and Isoniazide 150mg Tablets (FUNFUNATI-1)

We are a globally recognized pharmaceutical company specializing in the manufacturing, export, and supply of Rifampicin 300mg and Isoniazide 150mg Tablets (FUNFUNATI-1). With advanced production facilities in Vapi, Gujarat, we ensure the highest standards of quality, safety, and efficacy in every batch we deliver. Our commitment to excellence has positioned us among the most reliable suppliers across India, Africa, the Middle East, and Latin America.

Our fixed-dose combination tablets are developed in compliance with WHO-GMP and international regulatory standards, ensuring consistent therapeutic outcomes for patients suffering from tuberculosis.


Comprehensive Overview of Rifampicin and Isoniazide Tablets

Rifampicin 300mg and Isoniazide 150mg Tablets represent a highly effective combination therapy designed for the treatment and prevention of tuberculosis (TB). This formulation integrates two potent first-line anti-tubercular agents that work synergistically to eliminate Mycobacterium tuberculosis and prevent the emergence of drug resistance.

  • Rifampicin acts by inhibiting bacterial RNA synthesis, effectively stopping protein production necessary for bacterial survival.
  • Isoniazide disrupts the formation of the bacterial cell wall, weakening and ultimately destroying the pathogen.

Together, these mechanisms ensure rapid bacterial clearance and improved patient outcomes.


Key Benefits of Rifampicin 300mg and Isoniazide 150mg Tablets

1. Effective Tuberculosis Treatment

We manufacture this combination to deliver targeted action against both pulmonary and extra-pulmonary tuberculosis infections.

2. Improved Patient Compliance

Fixed-dose combinations reduce pill burden, simplifying treatment regimens and enhancing adherence.

3. Prevention of Drug Resistance

By combining two powerful antibiotics, we help minimize the risk of resistant TB strains.

4. Global Quality Assurance

Each tablet undergoes stringent quality checks, ensuring safety, potency, and stability across all export markets.


Indications and Usage

Our Rifampicin and Isoniazide Tablets are widely prescribed for:

  • Active tuberculosis infections
  • Latent TB prevention
  • Pulmonary and extrapulmonary TB
  • Combination therapy in TB treatment protocols

The medication is typically administered on an empty stomach, either one hour before or two hours after meals, to maximize absorption.


Dosage and Administration Guidelines

We recommend that these tablets be taken strictly under medical supervision. The dosage is determined based on body weight, severity of infection, and treatment phase.

  • Standard dosage: As prescribed by a healthcare professional
  • Administration: Oral, with water
  • Frequency: Usually once daily

Consistency in dosing is critical to ensure effective eradication of the infection.


Possible Side Effects

While generally well-tolerated, some patients may experience mild to moderate side effects, including:

  • Nausea and vomiting
  • Abdominal discomfort
  • Skin rash or itching
  • Dizziness and fatigue
  • Peripheral neuropathy (tingling or numbness)
  • Liver-related effects such as hepatitis
  • Low platelet count

Most side effects are temporary and resolve as the body adjusts. However, persistent symptoms should be evaluated by a healthcare provider.


Advanced Manufacturing Excellence in India

Our manufacturing unit in Vapi, Gujarat, is equipped with state-of-the-art technology and adheres to strict quality protocols. We maintain full compliance with international pharmaceutical guidelines, ensuring our products meet global standards.

Our Manufacturing Strengths Include:

  • WHO-GMP certified facilities
  • Advanced quality control laboratories
  • Highly skilled technical workforce
  • Automated production lines for precision and consistency
  • Robust packaging and logistics systems

Global Exporter of Rifampicin and Isoniazide Tablets

We are a leading exporter of Rifampicin 300mg and Isoniazide 150mg Tablets, supplying to multiple international markets:

  • Africa
  • Middle East
  • Latin America (LATAM)
  • Southeast Asia

Our global distribution network ensures timely delivery, regulatory compliance, and customized solutions for each market.


PCD Pharma Franchise Opportunities

We offer lucrative PCD pharma franchise opportunities for Rifampicin and Isoniazide Tablets across India. Our franchise partners benefit from:

  • Monopoly rights
  • Marketing and promotional support
  • High-quality product portfolio
  • Competitive pricing structure
  • Reliable supply chain

Our franchise model is designed to empower partners with sustainable growth and profitability.


Why Choose Us as Your Pharmaceutical Partner

1. Proven Industry Expertise

We bring years of experience in manufacturing anti-tubercular drugs with a strong reputation for quality and reliability.

2. Regulatory Compliance

Our products meet international standards, ensuring acceptance in regulated and semi-regulated markets.

3. Consistent Product Availability

We maintain large-scale production capabilities to meet bulk and urgent requirements.

4. Competitive Pricing

Our cost-effective solutions make high-quality medicines accessible across global markets.

5. Customer-Centric Approach

We prioritize client satisfaction through customized solutions, transparent communication, and dependable service.


Packaging and Supply Capabilities

We provide flexible packaging options to suit diverse market requirements:

  • Blister packs
  • Strip packaging
  • Bulk packaging for institutional supply

Our logistics team ensures safe, secure, and timely delivery worldwide.


Applications in Tuberculosis Control Programs

Our Rifampicin and Isoniazide Tablets are widely used in national and international TB control programs. Their proven efficacy and reliability make them a preferred choice for healthcare providers and government initiatives.

By supporting large-scale treatment programs, we contribute to global efforts aimed at eliminating tuberculosis.

Commitment to Quality and Innovation

We continuously invest in research and development to enhance product efficacy, stability, and patient compliance. Our quality assurance systems are designed to exceed industry standards, ensuring that every tablet delivers consistent therapeutic value.


As a trusted manufacturer, exporter, and supplier of Rifampicin 300mg and Isoniazide 150mg Tablets (FUNFUNATI-1), we remain committed to delivering superior pharmaceutical solutions for tuberculosis treatment. Our focus on quality, innovation, and global accessibility enables us to serve healthcare markets worldwide with confidence and reliability.

We continue to expand our presence across India and international regions, strengthening our position as a leading provider of anti-tubercular medications.